| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 477,727 | 401,109 | 385,865 | 407,633 | | Cost of Revenue | 255,806 | 238,786 | 243,822 | 279,055 | | | Gross Profit | 221,921 | 162,323 | 142,043 | 128,578 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 109,621 | 73,213 | 76,069 | 93,717 | | Non Recurring | (27,286) | 27,286 |
-
| 77,684 | | Others | 38,050 | 36,946 | 36,071 | 38,924 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 101,536 | 24,878 | 29,903 | (81,747) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11,285 | 16,577 | 21,645 | 880 | | Earnings Before Interest And Taxes | 120,119 | 34,102 | 52,943 | (84,190) | | Interest Expense | 30,535 | 31,817 | 28,949 | 33,949 | | Income Before Tax | 89,584 | 2,285 | 23,994 | (118,139) | | Income Tax Expense | 31,362 | (1,135) | 7,587 | (35,229) | | Minority Interest | (2,536) | (5,354) |
-
| (2,859) | | | | Net Income From Continuing Ops | 63,576 | (1,934) | 16,407 | (83,042) | | | Non-recurring Events | | Discontinued Operations | (1,361) | (2,612) | 81,675 | 10,006 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 53,929 | (4,546) | 98,082 | (73,036) | | Preferred Stock And Other Adjustments | 264 | 2,447 | (2,711) |
-
| | | Net Income Applicable To Common Shares | $54,193 | ($2,099) | $95,371 | ($73,036) |
|
0.51% Nasdaq 
Income Statement
